The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 145.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.399%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 145.00
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

22 Nov 2018 07:00

RNS Number : 1417I
Redcentric PLC
22 November 2018
 

22 November 2018

 

 

Redcentric plc

Half year results for the six months ended 30 September 2018 (unaudited)

Redcentric plc ("Redcentric" or "the Company") (AIM: RCN), a leading UK IT managed services provider, today announces its unaudited interim results for the six months to 30 September 2018.

 

Key financial measures

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change £m

Change %

Revenue (£m)

47.5

51.4

(3.9)

(7.6)%

Recurring monthly revenue (RMR) (£m)

41.3

44.6

(3.3)

(7.4)%

Adjusted EBITDA (£m)1

8.1

9.1

(1.0)

(11.0)%

Gross profit (£m)

28.4

30.5

(2.1)

(7.0)%

Gross margin (%)

59.8%

59.4%

4 bps

n/a

Adjusted basic EPS (p)2

1.89p

2.47p

(0.58)p

(23.5)%

Adjusted operating cash flow (£m)3

9.2

11.4

(2.2)

(19.3)%

Net debt (£m)4

22.6

33.3

(10.7)

(32.1)%

 

 

 

 

 

Statutory results

 

 

 

 

Operating profit (£m)

0.5

0.5

0.0

0.0%

Loss before tax (£m)

(0.1)

(0.0)

(0.1)

n/a

Cash generated from operations (£m)

8.8

10.5

(1.7)

(16.2)%

Basic EPS (p)

(0.38)p

(0.04)p

(0.34)p

n/a

 

1Adjusted EBITDA refers to underlying operating profit before depreciation, amortisation, non-recurring costs and share based payments.

2Adjusted basic earnings per share excludes amortisation of acquired intangibles, non-recurring items and share-based payments and replaces the reported tax credit with a notional tax charge at the full rate of corporation tax.

3Adjusted operating cash flow is before non-recurring items.

4Net debt is the sum of cash less bank loans and overdrafts and other financial liabilities.

 

Financial Highlights

· Recurring revenue maintained at 87% of total revenue.

· Continued strong cash flows with £9.2m of adjusted operating cash flow in the period (114% cash conversion).

· Net debt reduced by £5.1m over the six-month period.

· Further efficiencies and cost savings achieved across the operating cost base.

· Dividend reinstated with an interim dividend of 0.4p per share.

Operational Highlights

· Renewal and extension of major customer contracts to 2021 and beyond.

· Five health & social care network procurement awards.

· Launch of Managed Azure Services enabling customers to make better use of hyper cloud.

· Investment in systems, networks and hosting platforms with upgrades to core Redcentric network.

· Introduction of new sales CRM system and ongoing implementation of company-wide ERP system.

· Strong management of costs and migration of work to Hyderabad, India.

 

Chris Cole, Non-Executive Chairman, commented:

"During the period Redcentric has made strong progress with its programme of driving operational efficiencies, cost control and cash discipline. This work has led to a leaner, more efficient business and one that is able to respond more quickly in a dynamic industry. Despite these positives, top-line revenue performance has been disappointing and we have taken action to address this and return the business to organic revenue growth.

Representing the Board's confidence in the Company's outlook, I am pleased to report a reinstatement of the Company's dividend with an interim dividend of 0.4p per share."

 

For further enquiries please contact:

Redcentric plc +44 (0)1423 850 000

Peter Brotherton, Chief Financial Officer

Tulchan +44 (0)20 7353 4200

James Macey White / Matt Low

Numis Securities Limited - Nomad and Joint Broker +44 (0)20 7260 1000

Simon Willis / Oliver Hardy

finnCap Ltd - Joint Broker +44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

 

  

This announcement contains inside information. There will be a presentation for analysts held at 09:30hrs on 22 November 2018 at the offices of Tulchan Communications, 85 Fleet Street, EC4 1AE. Please contact redcentric@tulchanCompany.com if you would like to attend.

 

 

 

 

Half Year Review

For the six months to 30 September 2018

Overview

The results for the first half of the year reflect a mixed performance. Notwithstanding previously disclosed headwinds, the decline in revenue despite initiatives to reverse this is a source of particular disappointment. The Company continues to make good progress with cost control and cash discipline. However, the positive impact from these workstreams does not fully mitigate the revenue decline experienced in the period. Looking forward it is very clear that the business needs to return to top line growth and several further initiatives are being introduced to enable this. It is also equally clear that there are further opportunities to achieve material cost savings and efficiencies in the second half of this year and next year, which will support the ongoing profitability and cash generation of the business.

Financial Performance

Revenue reduced by 7.6% to £47.5m versus the prior period. Recurring monthly revenue, a key performance indicator for the Company, remained high at 87% of total revenue, but declined 7.4% versus the prior comparable period.

The shortfall in revenue resulted in a £2.1m reduction in gross profit which was partially offset by £1.1m of operating cost savings. As a result, adjusted EBITDA decreased by £1.0m or 11% to £8.1m.

Cash flows have remained strong during the half allowing a reduction in net debt from £27.7m at 31 March 2018 to £22.6m at 30 September 2018.

Business Performance

The Company's progress on delivering top line growth has been disappointing. Our contract win rates have been lower than expected and the quality of the new business pipeline has reduced. While our new sales director, Brendan Lynch, has made good initial progress in implementing the required changes, it is taking time to rebuild a high-quality sales function with a mature pipeline, especially in the private sector. At the same time the Health & Social Care Network (HSCN) contracts, despite having long-term potential, are now not expected to deliver the anticipated revenues in the timeframe previously expected, and the headwinds identified in prior announcements have continued.

Redcentric has continued to make considerable progress with its programme of operational efficiency, cost control and cash discipline. This has resulted in a business that is leaner, more responsive to changing customer requirements and more efficient. During the period under review we have continued to transition work to Hyderabad, our low-cost centre with a high-quality local talent pool, and are in the process of implementing a company-wide ERP system. It is pleasing that this substantial body of work has been delivered while retaining the high levels of customer service for which Redcentric is recognised. This is reflected in the renewal and extension of several major customer contracts through to 2021 and beyond.

Public Sector

In April 2018 Redcentric announced that it had been confirmed as the preferred supplier for Health & Social Care Network and Public Services Network (PSN) services to the Yorkshire and Humber region (YHSPN). This framework agreement covers local authorities, emergency services, transport and health sectors and will include connectivity to the new Health & Social Care Network and Public Services Network.

While this framework offers potentially significant long-term revenues, it has become clear during the period that it will fall short both in terms of overall value and the pace at which revenue growth will be delivered. Part of this delay has been outside of our control and related to issues typically associated with large and complex technology transition projects. In addition, issues of customer readiness and the administration of the framework have proved to be a notable headwind to progress. However, we have learned valuable lessons on actions we need to take to improve our engagement within our frameworks going forward. Our experience is that partners within the framework wish to re-evaluate their requirements rather than simply replacing existing services with Redcentric's products and services. There are limited options available to Redcentric in order to mitigate these factors albeit we are working closely with our partners in order to make progress.

During the period under review, Redcentric was appointed to three additional, smaller HSCN frameworks. With these other frameworks, we experienced similar headwinds to those mentioned above while pricing has also been aggressive in this market. As such, we currently anticipate a limited impact from HSCN contracts on FY19 and FY20 revenues but remain committed to the projects and are confident of a more meaningful contribution in subsequent periods. As an example of a recent HSCN contract, Redcentric won a five year connectivity contract worth a total of £1.8m with Worcester Health and Care NHS and we are looking to do more of these types of contracts in the future.

Private sector

Redcentric continues to successfully renew and expand contracts with its major clients. We have a track record in building long-term relationships with our clients focused on our high levels of customer service and reliability. Customer churn is largely driven through factors outside of our control such as M&A activity within our customer base. Despite our strong market position, over the past twelve months sales resource has been on the public sector. As previously referenced, this effort has not delivered the anticipated results. One of the initiatives actioned to take Redcentric forward is the re-focusing of the sales force on the private sector opportunity - particularly in verticals where Redcentric has a proven track record - which has traditionally been a core strength.

Cloud Transformation

The markets that Redcentric operate in are experiencing significant disruption and during the last twelve months we have developed new services to allow us to assist new and existing customers to navigate these changes. The nature of these new services, however, mean that sales cycles are longer, margins are typically lower and the revenue generated to date has been lower than planned.

Operational efficiencies and cost reductions

Management of costs has continued to be effective. We have exited from unprofitable non-strategic customer segments and introduced effective procurement practices which have more than offset other cost pressures such as higher energy charges. Building on Redcentric's sales CRM system launched in April, our new ERP platform will be introduced later this financial year, enabling us to drive further efficiency improvements, and accelerate our pace of business to meet rising customer expectations.

Board

Redcentric has separately announced today the resignation of Chris Jagusz from his directorship and position as Chief Executive Officer. Peter Brotherton, Chief Financial Officer, will temporarily assume Chief Executive responsibilities while a formal process to appoint a permanent Chief Executive is carried out. We thank Chris for his efforts and wish him the best with his future endeavours.

Taking the business forward

There are two priorities to take Redcentric forward. The first is to continue the progress made in making the business more efficient, with a sustainable and right-sized cost base. Secondly, actions are being undertaken which will start to drive revenue growth. Plans are in place to deliver on both of these priorities.

We have well developed plans to further improve the operational efficiency of the business, reduce the cost base significantly and transfer further work across to Hyderabad. In addition, we have identified several areas which we intend to focus on in order to drive sustainable revenue growth. The sales team, and the sales support experts around them, will be strengthened both via recruitment and through the transition of skilled resource to customer facing roles. The team will be incentivised to build a credible, well-qualified sales pipeline, particularly in the private sector. Historically, this was a core strength of Redcentric. We still have major customers in this area where we remain a leading provider of services to mid-market businesses, especially those with dispersed infrastructure, such as multi-site operators. We believe that this can be a key area of future growth.

Industry change and shifting client expectations of their IT provider necessitate consistent re-evaluation of our product suite and development focus to ensure they are relevant to the market and can contribute to Redcentric's future performance. Given this, we intend to review the performance and outlook of the Cloud Transformation Practice to provide confidence that continued investment and development is the correct allocation of capital and resource in order to succeed in the present and future market.

Investment in new capabilities will continue, supported by the continued cash generation of the Company. This spend will be concentrated around our core competencies in connectivity and collaboration and allow us to take advantage of our differentiating capabilities in networking. This will, in time, de-emphasise our dependency on hosting-only contracts where competitive pressures are most intense.

Given the ongoing consolidation within the industry the Company will continue to evaluate selectively the opportunities available to it.

Dividend

Reflecting its confidence in the outlook for Redcentric, the Board has decided to reinstate the dividend with an interim payment of 0.4p per share for the period under review. This represents the implementation of a prudent dividend policy.

Summary and outlook

Redcentric has been successful at retaining key customers in the period and maintaining its reputation for customer service. In addition, further progress has been made on reducing costs and managing cash which has enabled a significant reduction in net debt and the reinstatement of a dividend. However, this has been offset by a disappointing performance in revenue.

Looking forward, there are two strategic priorities. The first is to continue streamlining the business where there is the potential for further significant cost savings and efficiency improvements. Secondly, returning the business to organic revenue growth. We have identified the areas where we believe we can utilise Redcentric's strengths to achieve this particularly within the private sector. Changes are being made to the Company's sales team structure and areas of focus aligned to these growth areas. Given these initiatives the Board expects that the rate of revenue decline will slow in H2 19 and return to growth in FY20. The Board also expects that profits and net debt for FY19 will be in-line with its expectations.

A process is underway to appoint a new Chief Executive and we look forward to updating the market on progress in due course. 

Finance Review

 

Financial highlights and overview

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

Statutory financial reporting measures

 

 

 

 

 

 

 

 

 

Revenue

£47.5m

£51.4m

£(3.9)m

(7.6)%

Operating profit

£0.5m

£0.5m

£0.0m

0.0%

Basic loss per share

(0.38)p

(0.04)p

(0.34)p

-

 

 

 

 

 

Adjusted performance measures (APMs)

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

£8.1m

£9.1m

£(1.0)m

(11.0)%

Adjusted EBITDA margin

17.1%

17.7%

 

6 bps

Adjusted cash generated from operations

£9.2m

£11.4m

£(2.2)m

(19.0)%

Adjusted cash conversion

113.8%

125.0%

 

11.2 bps

Adjusted operating profit

£4.1m

£5.3m

£(1.2)m

(22.6)%

Adjusted basic earnings per share

1.89p

2.47p

(0.58)p

(23.5)%

 

 

The Directors use the APMs listed above as they are critical to understanding the financial performance of the Company. As they are not defined by IFRS, they may not be directly comparable with other companies who use similar measures.

 

 

APM

Definition

Reconciliation to equivalent IFRS measure of performance

Adjusted EBITDA

Earnings before interest, tax, depreciation, amortisation, exceptional costs and share-based payments

A reconciliation of this measure is provided in the consolidated income statement

Adjusted EBITDA margin

Adjusted EBITDA to revenue

Adjusted EBITDA excluding exceptional costs and share-based payments

 

Adjusted cash generated from operations

Adjusted EBITDA plus working capital movements

Adjusted EBITDA plus working capital movements

Adjusted cash conversion

Adjusted cash generated from operations to adjusted EBITDA

Cash generated from operations to EBITDA

Adjusted operating profit

Operating profit add amortisation on acquired intangibles, exceptional costs and share based payments

Operating profit as disclosed on the consolidated income statement

Adjusted basic earnings per share

Adjusted earnings - profit/loss add amortisation (acquired intangibles), share based payments, exceptional costs, tax charge/credit

A reconciliation of this measure is provided in Note 8

Adjusted operating costs

Operating costs less depreciation, amortisation and share based payments

Operating expenditure as outlined in the consolidated income statement

 

 

Revenue

Recurring revenue for the six months to 30 September 2018 was £41.3m, a reduction of £3.3m on the equivalent period last year.

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

 

£'000

£'000

£'000

%

Recurring monthly revenue

41,322

44,644

(3,322)

(7.4)%

Product sales

3,328

4,121

(793)

(19.2)%

One off service revenue

2,802

2,609

193

7.4%

 

47,452

51,374

(3,922)

(7.6)%

 

The Company's prime focus is on recurring monthly revenues ("RMR"), product and service sales are undertaken to support the recurring revenue base. Product and Services revenues can fluctuate from period to period.

The key revenue metric of RMR was 7.4% lower than the equivalent period last year and accounted for 87% of total revenue (H1 FY17/18: 87%).

 

Gross profit

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

 

£'000

£'000

£'000

%

Gross profit

28,368

30,507

(2,139)

(7.0)%

 

 

 

 

 

Gross margin

59.8%

59.4%

 

 

 

Gross profit decreased by £2.1m largely reflecting the reduction in recurring revenue as above, as well as demonstrating the effect of product mix. Product sales at lower margin were reduced in H1 FY18/19, resulting in an uplift to overall gross margin.

 

Adjusted Operating costs

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

 

£'000

£'000

£'000

%

Staff costs

10,480

11,940

(1,460)

(12.2)%

Office and data centre costs

3,462

3,589

(127)

(3.5)%

Network and equipment costs

3,708

3,286

422

12.8%

Other sales, general and administration costs

1,463

1,575

(112)

(7.1)%

Offshore costs

1,140

999

141

14.1%

 

20,253

21,389

(1,136)

(5.3)%

 

Adjusted operating costs excludes depreciation, amortisation, non-recurring costs and share based payments.

 

Employees

Half Year End Headcount

30 Sept 2018

30 Sept 2017

Change

Change %

UK

331

366

(35)

(9.6)%

India

153

140

13

9.3%

Total

484

506

(22)

(4.3)%

 

Average headcount

30 Sept 2018

30 Sept 2017

Change

Change %

UK

337

377

(40)

(10.6)%

India

146

142

4

2.8%

Total

483

519

(36)

(6.9)%

 

Overall, adjusted operating costs for H1 FY18/19 were £1.1m (5.3%) lower compared to the equivalent period last year. The majority of this cost reduction has been realised through a reduced UK headcount and therefore a reduced staff cost spend. There has been a strategic initiative to move UK operational roles to Hyderabad where possible to reduce costs whilst maintaining quality of service. This has been largely achieved through natural attrition.

Office and data centre costs were down on the equivalent period last year reflecting the annualisation of savings from the closure of the London office and exit from a third-party data centre.

Network and equipment costs have increased half year on half year by £0.4m, mainly due to increased licensing costs in relation to Microsoft Dynamics 365 and the associated investment in the new ERP system.

Other sales, general and administration costs have reduced compared to the equivalent period last year. Whilst there has been an investment in the first half of the year in consultancy costs to help support the YHPSN bid, these increased costs have been offset by reductions across, marketing and corporate costs.

Costs relating to the offshore operation have increased slightly due to the increase in staff following the transfer of certain roles from the UK.

 

Adjusted Earnings Before Interest, Taxation, Depreciation and Amortisation (EBITDA)

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

 

£'000

£'000

£'000

%

Adjusted EBITDA

8,115

9,118

(1,003)

(11.0)%

Adjusted EBITDA margin

17.1%

17.7%

 

 

 

Adjusted EBITDA is the key measure that the Company uses to assess the underlying profitability of the business. Adjusted EBITDA excludes non-recurring items and share based payments.

Adjusted EBITDA decreased by £1.0m or 11.0% to £8.1m reflecting a reduction in gross profit that has been partially mitigated by savings made across operating costs.

 

Non-recurring items

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

 

£'000

£'000

£'000

%

Professional fees associated with the forensic review and Financial Conduct Authority (FCA) investigation

243

509

(266)

(52.3)%

Integration & restructuring

-

840

(840)

(100.0)%

 

243

1,349

(1,106)

(82.0)%

 

Overall, the level of non-recurring items has decreased from £1.3m to £0.2m. The only material costs classified as non-recurring are in relation to the ongoing FCA investigation and corresponding legal advice. The Board and Senior Management continue to fully co-operate with the FCA to aid with the investigation, however any timescales for resolution have not yet been indicated.

  

 

Net financing costs

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Change

 

£'000

£'000

£'000

%

Interest receivable

 

 

 

 

Other interest receivable

(12)

(257)

245

95.3%

 

 

 

 

 

Interest payable

 

 

 

 

Interest payable on bank loans and overdrafts

550

724

(174)

(24.0)%

Amortisation of loan arrangement fees

34

34

-

-

 

584

758

(174)

(23.0)%

 

 

 

 

 

Net financing costs

572

501

71

14.2%

 

The reduction in interest payable costs in H1 FY18/19 reflects the reduction of the outstanding balance drawn down on the revolving credit facility from £32.0m at September 2017 to £24.5m at September 2018.

 

Taxation

Current tax for the six-month period represents the best estimate of the average annual effective tax rate expected for the full year, applied to the pre-tax income of the six-month period. Deferred tax is calculated based on the expected annual outturn. The charge to the condensed consolidated statement of comprehensive income reflects:

i) Adjustments to prior year tax of £0.4m

ii) Overseas tax paid via Redcentric Solutions Private Ltd, a wholly owned subsidiary of the Company incorporated in India, £0.1m

iii) Movement in the deferred tax liability £(0.1)m

iv) Corporation tax due on trading profits in the year after the effects of loss streaming

 

During the six months to 30 September 2018, £1.6m of trading losses were utilised leaving a balance of £17.1m outstanding.

 

 

Earnings per share

Basic adjusted earnings per share for H1 FY18/19 was 1.89p, compared to 2.47p in H1 FY17/18. Diluted adjusted earnings per share for H1 FY18/19 was 1.88p compared to 2.38p in H1 FY17/18 (see note 8).

 

Dividends

In these results the Board is announcing the reinstatement of a dividend. An interim payment of 0.4p per share will be paid on 21 December 2018. The shares will have an ex-dividend date of 29 November 2018 and a record date of 30 November 2018.

 

Financial position

The summary financial position of the Company is set out below:

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended 31 March 2018

 

£'000

£'000

£'000

Non-current assets

98,609

107,510

102,724

Net current assets (excl. net debt)

2,500

5,582

3,326

Non-current liabilities (excl. net debt)

(1,036)

(2,819)

(421)

Net debt

(22,621)

(33,324)

(27,707)

Net assets

77,452

76,949

77,922

 

Net debt and cash flows

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended 31 March 2018

 

£'000

£'000

£'000

Revolving credit facility

24,500

32,000

28,000

Term loans

-

2

-

(Cash) balance

(6,282)

(4,692)

(6,089)

Finance leases

4,505

6,184

5,932

Unamortised loan arrangement fees

(102)

(170)

(136)

Net Debt

22,621

33,324

27,707

 

During H1 FY18/19, net debt fell from £27.7m at 31 March 2018 to £22.6m at 30 September 2018. The movements in net debt are analysed below along with the prior half year comparative.

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

 

£'000

£'000

Adjusted EBITDA

8,115

9,118

Working capital movements

1,120

2,278

Adjusted cash generated from operations

9,235

11,396

Cash conversion

113.8%

125.0%

 

 

 

Corporation tax

(38)

(55)

Adjusted net cash inflow from operating activities

9,197

11,341

 

 

 

Net debt movements from investing activities

 

 

Purchase of property, plant and equipment

 

 

- Cash purchases

(2,884)

(2,276)

- Finance lease purchases

(185)

(1,464)

 

(3,069)

(3,740)

Net debt movements from financing activities

 

 

Interest paid

(545)

(665)

 

 

 

Non cash movements in net debt

 

 

Amortisation of loan arrangement fees

(34)

(34)

Effect of exchange rates

(32)

(16)

 

 

 

Decrease in net debt pre non-recurring items

5,517

6,886

 

 

 

Non-recurring net debt movements

 

 

Non-recurring expense items

(431)

(936)

Non-recurring interest income

-

257

 

(431)

(679)

Decrease in net debt at 30 Sept 2018/ 2017

5,086

6,207

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

 

£'000

£'000

 

 

 

Net debt at 31 March

(27,707)

(39,531)

 

 

 

Net decrease in net debt

5,086

6,207

 

 

 

Net debt at 30 September

(22,621)

(33,324)

 

Working capital movements

Working capital movements total £1.1m, of which £2.9m relate to trade debtors, accrued income, deferred income and other debtors. This resulted in cash conversion in the period of 114% compared to 125% in the prior period.

Trade debtor days were 44 at 30 September 2018 compared to 57 in the comparative period.

 Trade creditor days were 31 at 30 September 2018 compared to 25 in the comparative period.

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended 31 March 2018

 

£'000

£'000

£'000

Current

7,946

 10,297

11,323

1 to 30 days overdue

1,112

 1,957

1,951

31 to 60 days overdue

1,150

 1,647

1,417

61 to 90 days overdue

182

 628

550

91 to 180 days overdue

470

1,261

945

> 180 days overdue

382

1,802

593

Gross trade debtors

11,242

 17,592

16,779

Trade debtor impairment provision

(1,057)

(1,864)

(981)

Net trade debtors

10,185

15,728

15,798

 

Financing and covenants

The Company's committed facilities at 30 September 2018 were £40m (H1 FY17/18: £40m). In addition to this, the Company has access to a £3m overdraft facility, a £6m finance lease facility and a £10m accordion facility.

As at 30 September 2018, the Company had drawn £25m on its revolving credit facility leaving headroom of £15m.

Post the half year end, £10m of the RCF was cancelled leaving a committed facility of £30m.

The Company's banking facilities are in place until 31 March 2020.

 

 

 

Responsibility Statement

The Directors are responsible for preparing the Interim Report in accordance with applicable law and regulations. The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company, and enable them to ensure that its financial statements comply with the Companies Act 2006. They have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Company and to prevent and detect fraud and other irregularities.

The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the UK governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

By Order of the Board

 

 

 

 

Peter Brotherton

Chief Financial Officer

22 November 2018

 

 

 

 

 

Cautionary Statement

To the shareholders of Redcentric plc

The Interim report and accounts have been prepared solely to provide additional information to shareholders to assess the Company's strategies and the potential for those strategies to succeed. The report and accounts should not be relied on by any other party or for any other purpose. The report and accounts contains some forward looking statements. These statements are made by the directors in good faith based on information available to them at the time of their approval of this report, but such statements should be treated with caution due to the inherent uncertainties, including both economic and business factor risks, underlying any such forward looking information.

 

 

Consolidated income statement for the six months ended 30 September 2018 (unaudited)

 

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

Note

£'000

£'000

£'000

Revenue

3

47,452

51,374

99,990

Cost of sales

 

(19,084)

(20,867)

(39,996)

Gross Profit

 

28,368

30,507

59,994

Operating expenditure

 

(27,918)

(30,034)

(59,054)

Operating Profit

 

450

473

940

 

 

 

 

 

Analysed as:

 

 

 

 

Adjusted EBITDA*

4

8,115

9,118

18,085

Depreciation

 

(3,493)

(3,679)

(7,769)

Amortisation of intangibles

 

(3,689)

(3,272)

(7,136)

Non-recurring costs

5

(243)

(1,349)

(1,672)

Share-based payments

 

(204)

(345)

(534)

NI on share-based payments

 

(36)

-

(34)

Operating Profit

 

450

473

940

 

 

 

 

 

Net Finance costs

6

(572)

(501)

(1,433)

Loss on ordinary activities before taxation

 

(122)

(28)

(493)

Tax credit/(charge) on profit on ordinary activities

7

(449)

(36)

1,004

Profit/(Loss) for the year (attributable to owners of the parent)

 

(571)

(64)

511

 

 

 

 

 

Basic earnings/(loss) per share

8

(0.38)p

(0.04)p

0.34p

Diluted earnings/(loss) per share

 

(0.38)p

(0.04)p

0.34p

 

*Adjusted EBITDA refers to underlying operating profit before depreciation, amortisation, non-recurring costs and share based payments

  

Consolidated statement of comprehensive income (unaudited)

 

Six months ended 30 Sept 2018

Six months ended 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Profit/(Loss) for the period

(571)

(64)

511

Exchange differences arising on re-translation of foreign subsidiary

(28)

(2)

(45)

Total comprehensive Profit/(loss) for the period

(599)

(66)

466

 

 

Consolidated statement of changes in equity (unaudited)

 

 

Share Capital

Share Premium

Capital Redemption Reserve

Retained Earnings

Total Equity

 

£'000

£'000

£'000

£'000

£'000

 

Balance at 31 March 2017

149

65,395

(9,454)

20,639

76,729

 

 

 

 

 

 

Loss for the period

-

-

-

(64)

(64)

Other comprehensive loss - before tax

-

-

-

(2)

(2)

Total comprehensive income

-

-

-

(66)

(66)

 

 

 

 

 

 

Transactions with owners:

 

 

 

 

 

Deferred tax on share-based payments

-

-

-

(59)

(59)

IFRS2 charge

-

-

-

345

345

Balance at 30 September 2017

149

65,395

(9,454)

20,859

76,949

 

Profit for the period

-

-

-

575

575

Other comprehensive loss - before tax

-

-

-

(43)

(43)

Total comprehensive income

-

-

-

532

532

 

 

 

 

 

 

Transactions with owners:

 

 

 

 

 

Issue of new shares

-

193

-

-

193

Deferred tax on share-based payments

-

-

-

59

59

IFRS2 charge

-

-

-

189

189

Balance at 31 March 2018

149

65,588

(9,454)

21,639

77,922

 

Adjustment on initial application of IFRS 15

 

 

 

(75)

(75)

 

 

 

 

 

 

Loss for the period

 

 

 

(571)

(571)

Other comprehensive loss - before tax

 

 

 

(28)

(28)

Total comprehensive income

 

 

 

(599)

(599)

 

 

 

 

 

 

Transactions with owners:

 

 

 

 

 

IFRS2 Charge

 

 

 

204

204

Balance at 30 September 2018

149

65,588

(9,454)

21,169

77,452

 

  

Consolidated balance sheet as at 30 September 2018 (unaudited)

 

 

 

30 Sept 2018

30 Sept 2017

31 March 2018

 

Note

£'000

£'000

£'000

Non-Current Assets

 

 

 

 

Property, plant and equipment

9

19,173

22,058

20,238

Intangible assets and goodwill

10

79,436

85,452

82,486

 

 

98,609

107,510

102,724

Current Assets

 

 

 

 

Inventories

 

443

232

666

Trade and other receivables

11

22,510

25,323

26,120

Corporation tax receivable

 

-

395

-

Cash and short term deposits

 

6,282

4,692

6,089

 

 

29,235

30,642

32,875

 

 

 

 

 

Total assets

 

127,844

138,152

135,599

 

 

 

 

 

Equity

 

 

 

 

Called up share capital

15

149

149

149

Share premium account

 

65,588

65,395

65,588

Capital redemption reserve

 

(9,454)

(9,454)

(9,454)

Retained earnings

 

21,169

20,859

21,639

Total Equity

 

77,452

76,949

77,922

 

 

 

 

 

Non-current liabilities

 

 

 

 

Loans and borrowings

14

25,812

35,337

30,671

Provisions

13

530

309

376

Deferred tax liability

 

506

2,177

45

 

 

26,848

37,823

31,092

Current Liabilities

 

 

 

 

Trade and other payables

12

19,617

20,368

22,570

Corporation tax payable

 

836

-

890

Loans and borrowings

14

3,091

2,679

3,125

Provisions

13

-

333

-

 

 

23,544

23,380

26,585

 

 

 

 

 

Total Liabilities

 

50,392

61,203

57,677

 

 

 

 

 

Total Equity and Liabilities

 

127,844

138,152

135,599

 

 

Consolidated cash flow statement for the six months ended 30 September 2018 (unaudited)

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

 

 

 

 

Cash flows from operating activities

 

 

 

 

Loss before taxation

(122)

(28)

(493)

Net finance expense

572

501

1,433

Operating profit

450

473

940

Depreciation and amortisation

7,182

6,951

14,905

Non-recurring items

243

1,349

1,672

Share based payments

240

345

568

Operating cash flow before non-recurring costs and movements in working capital

8,115

9,118

18,085

Non-recurring costs and NI on share based payments

(431)

(937)

(3,002)

Operating cash flow before movements in working capital

7,684

8,181

15,083

Decrease/(increase) in inventories

223

2

(432)

Decrease in trade and other receivables

1,364

665

1,079

(Increase)/decrease in trade and other payables

(466)

1,611

3,912

Cash generated from operations

8,805

10,459

19,642

Corporation tax (paid)/received

(38)

(55)

217

Net cash inflow from operating activities

8,767

10,404

19,859

 

 

 

 

Cash flows from investing activities

 

 

 

 

Purchase of property, plant and equipment

(2,884)

(2,276)

(3,983)

Net cash outflow from investing activities

(2,884)

(2,276)

(3,983)

 

 

 

 

Cash flows from financing activities

 

 

 

 

Interest paid

(545)

(462)

(1,196)

Finance fees paid on bank loans

-

(50)

(50)

Repayment of borrowings

-

(321)

(323)

Repayment of revolving credit facility

(3,500)

(6,000)

(10,000)

Proceeds of issue of shares less costs of issue

-

-

193

Finance Lease repayments

(1,613)

(927)

(2,795)

Net cash inflow from financing activities

(5,658)

(7,760)

(14,171)

 

 

 

 

Net increase in cash and cash equivalents

225

368

1,705

 

 

 

 

Opening cash and cash equivalents

6,089

4,340

4,340

Net increase in cash and cash equivalents

225

368

1,705

Effect of exchange rates

(32)

(16)

44

Cash and cash equivalents at end of the period

6,282

4,692

6,089

 

The accompanying notes form part of these financial statements.

 

  

Notes to the interim financial statements for the six months ended 30 September 2018

1. General information

Reporting entity

Redcentric plc ('the Company') is a company domiciled in England and Wales. These condensed consolidated interim financial statements ('interim financial statements') as at and for the six months to 30 September 2018 comprise the Company and its subsidiaries (together referred to as 'the Company'). The principal activity of the Company is the supply of IT managed services.

 

2. Accounting policies

Basis of accounting

These interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting, and should be read in conjunction with the Company's last annual consolidated financial statements as at and for the year ended 31 March 2018 ('last annual financial statements'). They do not include all of the information required for a complete set of IFRS financial statements. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Company's financial position and performance since the last annual financial statements.

The information for the year ended 31 March 2018 does not constitute statutory accounts as defined in section 435 of the Companies Act 2016. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The auditors reported on those accounts.

Use of judgements and estimates

In preparing these interim financial statements, management has made judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

The significant judgements made by management in applying the Company's accounting policies and the key sources of estimation uncertainty were the same as those that applied to the consolidated financial statements as at and for the year ended 31 March 2018.

Going concern

The directors have prepared a detailed trading and cash flow forecast for a period which covers at least 12 months after the date of approval of these condensed interim financial statements. Having considered the forecasts and making other enquiries, the directors have a reasonable expectation that Redcentric has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the condensed interim financial statements.

Significant accounting policies

The accounting policies applied in these interim financial statements are mostly the same as those applied in the last annual financial statements, however the Company has now adopted IFRS 9 and IFRS 15.

IFRS 9 Financial Instruments was issued by the IASB in July 2014 and is effective for the Company for the year ended 31 March 2019. Applying IFRS 9 has resulted in changes to the measurement and disclosure of financial instruments and introduced a new expected loss impairment model. Regarding impairment, the Company has applied the IFRS 9 approach to measuring expected credit losses which uses a lifetime expected loss allowance for all assets held at amortised cost. The impact of the change in impairment methodology was not material.

IFRS 15 'Revenue from contracts with customers' is effective for periods beginning on or after 1st January 2018. The Company has adopted IFRS 15, 'Revenue from Contracts with Customers', for the year ending 31 March 2019. This establishes a comprehensive framework for determining whether, how much and when revenue is recognised. As permitted by the standard, the Company has taken advantage of the modified transitional provisions and the results for the year ended 31 March 2018 remain as previously reported. Under the modified approach the cumulative approach of initially applying the standard is recognised at 1 April 2018 with no restatement of prior periods. The overall impact on reserves as at the transition date is not significant. Further details relating to IFRS15 are disclosed in note 16

Standards issued but not yet effective

IFRS 16 'Leases' introduces a single lessee accounting model and is effective for periods beginning on or after 1st January 2019. The new standard will require lessees to recognise a lease liability reflecting the obligation to make future lease payments and a 'right-of-use' asset for all leases unless exemption is taken for certain short-term leases or for leases of low-value assets. The Company is currently assessing the impact of the new standard and it is not practicable to quantify the effect of this standard until this detailed review has been completed. The Company expects to adopt the standard from 1st April 2019 and will be considering whether to use fully or modified retrospective application.

 

3. Business segments

 

As applied to the consolidated financial statements as at and for the year ended 31 March 2018, the Board believes that the Company comprises a single reporting segment being the provision of managed services to customers. Whilst the Board still reviews revenue streams of the three categories separately; recurring, product and service revenue, the operating costs and operating asset base used to derive these revenue streams are the same for all three categories and are presented as such in the Company's internal reporting.

 

4. Adjusted Earnings Before Interest, Tax, Depreciation and Amortisation (Adjusted EBITDA)

 

Management has presented the performance measure adjusted EBITDA because it believes that this measure is relevant to an understanding of the Company's financial performance. The definition of adjusted EBITDA is the same as in the last annual financial statements. Adjusted EBITDA is not a defined performance measure in IFRS. The Company's definition of adjusted EBITDA may not be comparable with similarly titled performance measures and disclosures by other entities.

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Operating Profit

450

473

940

Adjustments for:

 

 

 

Depreciation

3,493

3,679

7,769

Amortisation of Intangibles

3,689

3,272

7,136

Non-recurring costs

243

1,349

1,672

Share-based payments

240

345

568

Adjusted EBITDA

8,115

9,118

18,085

 

5. Non-recurring costs

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Professional fees associated with the forensic review and Financial Conduct Authority (FCA) investigation

243

509

672

Integration & restructuring

-

840

1,000

 

243

1,349

1,672

 

Overall, the level of non-recurring items has decreased from £1.1m to £0.2m. The only material costs being treated as non-recurring are in relation to the ongoing FCA investigation and related to legal advice. The Board and Senior Management continue to fully co-operate with the FCA to aid with the investigation, however any timescales for resolution have not yet been indicated. 

 

6. Finance costs

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Interest receivable

 

 

 

Other interest receivable

(12)

(257)

(19)

 

 

 

 

Interest payable

 

 

 

Interest payable on bank loans and overdrafts

550

724

1,384

Amortisation of loan arrangement fees

34

34

68

 

584

758

1,452

 

 

 

 

Net financing costs

572

501

1,433

 

 

7. Taxation

 

Tax of profit on ordinary activities

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Current income tax

251

46

331

Adjustment to prior year

(262)

-

696

Overseas tax

 

 

53

Deferred tax:

 

 

 

Origination and reversal of timing differences:

 

 

 

- Deferred tax asset: adjustment to prior year

698

-

(604)

- Deferred tax asset: current year

-

521

 

- Deferred tax liability: adjustment to prior year

-

(531)

(410)

- Deferred tax liability: current year

(238)

-

(1,070)

Total income tax charge/(credit) reported in the income statement

449

36

(1,004)

 

Reconciliation of the total income tax charge/(credit)

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Profit /(Loss) before taxation

(122)

(28)

(493)

Profit multiplied by the UK standard rate of corporation tax of 19%

(23)

(4)

(94)

Expenses not deductible for tax purposes

47

28

53

Share scheme deduction under Part 12 CTA 2009

 

 

(12)

Movement in unprovided tax losses

(30)

-

(1,000)

Adjustment to prior year

416

-

92

Effect of tax rate change

23

1

28

Impact of overseas tax rates

16

11

8

Tangible Asset timing difference

-

-

(79)

Total income tax charge/(credit) reported in the income statement

449

36

(1,004)

 

 

8. Earnings per share

 

Basic earnings per share have been calculated using a weighted average number of shares of 149,135,316 (H1 FY17/18: 148,859,173). The dilutive effect of share options in issue at 30 September 2018 increased the weighted average number of shares to 150,589,987 (H1 FY17/18: 154,641,819).

In addition, adjusted earnings per share have been calculated to reflect the underlying performance of the business. This measure is derived as follows:

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March 2018

 

£'000

£'000

£'000

Statutory earnings/(loss)

(571)

(64)

511

Amortisation of acquired intangibles*

3,126

3,126

6,252

Share-based payments

240

345

568

Tax (credit)/charge in income statement

449

36

(1,004)

Non-recurring interest

-

(257)

-

Non-recurring costs

243

1,349

1,672

Adjusted earnings before tax

3,487

4,535

7,999

Notional tax charge at 19%; (H1 FY16: 20%; FY17 20%)

(662)

(862)

(1,520)

Earnings for the purpose of earnings per share being net profit attributable to owners of the Company

2,825

3,673

6,479

 

 

 

 

Weighted average number of ordinary shares for the purposes of basic earnings per share

149,135,316

148,859,173

148,890,948

Weighted average number of ordinary shares for the purposes of diluted earnings per share

150,589,987

154,641,819

149,871,477

 

 

 

 

Statutory earnings/(loss) per share - basic

(0.38)p

(0.04)p

0.34p

Statutory earnings/(loss) per share - diluted

(0.38)p

(0.04)p

0.34p

Adjusted earnings per ordinary share - basic

1.89p

2.47p

4.35p

Adjusted earnings per ordinary share - diluted

1.88p

2.38p

4.32p

 

Reconciliation of Amortisation

Amortisation charge per P&L

3,689

3,272

7,136

Amortisation of software

(563)

(146)

(884)

*Amortisation of acquired intangibles

3,126

3,126

6,252

  

 

9. Tangible Assets

 

 

 

Leasehold improvements

£000

Office fixtures and fittings£000

Vehicles & computer equipment£000

Total£000

Cost

 

 

 

 

At 31 March 2018

13,896

1,372

29,837

45,105

Additions

88

54

2,422

2,564

Reclassification to intangible assets

 

 

(194)

(194)

Exchange differences

-

-

(12)

(12)

At 30 September 2018

13,984

1,426

32,053

47,463

 

 

 

 

 

Accumulated depreciation

 

 

 

 

At 31 March 2018

9,526

1,002

14,339

24,867

Charge for the half year ended 30 Sept 2018

248

48

3,197

3,493

Reclassification to intangible assets

 

 

(59)

(59)

Exchange differences

-

-

(11)

(11)

At 30 September 2018

9,774

1,050

17,466

28,290

 

 

 

 

 

Net book amount

 

 

 

 

At 30 September 2018

4,210

376

14,587

19,173

At 31 March 2018

4,370

370

15,498

20,238

 

 

Included in vehicle and computer equipment are assets held under finance leases with a carrying value of £3.5m at 30 September 2018 (H1 FY17/18: £6.2m). Of the £2.5m fixed assets acquired in the year, £nil were funded using finance leases (H1 FY17/18 £0.9m). 

 

10. Intangible assets

 

 

 

 

 

Goodwill

£000

Customer contracts and related relationships

£000

 

 

 

Trademarks

£000

 

 

Software & Licences

£000

 

 

 

Total

£000

Cost

 

 

 

 

 

At 31 March 2017

43,269

62,300

275

4,700

110,544

Additions

-

-

-

913

913

FOREX difference on carrying value

-

(16)

-

-

(16)

At 31 March 2018

43,269

62,284

275

5,613

111,441

Additions

-

-

-

504

504

Reclassification from tangible assets

 

 

 

194

194

Exchange differences

 

 

 

(1)

(1)

At 30 September 2018

43,269

62,284

275

6,310

112,138

 

 

 

 

 

 

Accumulated amortisation and impairment

 

 

 

 

 

At 31 March 2017

-

19,596

240

1,983

21,819

Amortisation charge for the year ended 31 March 2018

-

6,217

35

884

7,136

At 31 March 2018

-

25,813

275

2,867

28,955

Amortisation charge for the half year ended 30 September 2018

-

3,126

-

563

3,689

Reclassification from tangible assets

 

 

 

59

59

Exchange differences

 

 

 

(1)

(1)

At 30 September 2018

-

28,939

275

3,488

32,702

 

 

 

 

 

 

Carrying amount at 30 September 2018

43,269

33,345

-

2,822

79,436

Carrying amount at 31 March 2018

43,269

36,471

-

2,746

82,486

 

 

Included in software and licences are intangibles assets held under finance leases with a carrying value of £0.7m at 30 September 2018 (2017: £nil). Of the £0.5m intangible assets acquired in the year, £0.2m were funded using finance leases (2017: £nil).

Intangible assets are reviewed for impairment at least annually or more frequently if events or changes in circumstances indicate that the carrying value may be impaired. In the half year to 30 September 2018, there have been no such events that might trigger an impairment review. 

 

11. Trade and other receivables

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March 2018

 

£'000

£'000

£'000

Trade Receivables

11,242

17,592

16,779

Less: Provision for impairment of trade receivables

(1,057)

(1,864)

(981)

Trade receivables - net

10,185

15,728

15,798

Other receivables

270

224

265

Prepayments

8,170

6,151

7,211

Accrued income

3,885

3,220

2,846

Total

22,510

25,323

26,120

 

Through the adoption and implementation of IFRS 9, the Company has reviewed its approach to expected credit losses to ensure that the current policy is compliant and reflects the early recognition of any expected debtor impairment. The current policy was found to adhere to the guidelines of IFRS 9 as trade receivable credit provisions are made at the point of revenue recognition.

 

12. Trade and other payables

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March 2018

 

£'000

£'000

£'000

Trade Payables

6,524

6,122

9,005

Other Payables

233

1,004

27

Taxation and Social Security

2,142

2,667

2,490

Accruals

2,959

3,598

2,705

Deferred Income

7,759

6,977

8,343

Total

19,617

20,368

22,570

 

13. Provisions

 

 

Dilapidations -

Total Provision

 

£'000

At 31 March 2018

376

 

 

Additional provisions created during the year

154

Utilisation of provision

-

Reclassification of provision

-

At 30 September 2018

530

 

 

 

 

Dilapidation provisions are made in respect of contractual obligations relating to leased property. Vacant property provisions are made in respect of vacated properties under onerous leases.

 

 

At 30 September 2018

At 30 September 2017

 

Dilapidations

Vacant Property

Total

Dilapidations

Vacant Property

Vacant Property

 

£'000

£'000

£'000

£'000

£'000

£'000

 

 

 

 

 

 

 

Current

-

-

-

21

312

333

Non-current

530

-

530

309

-

309

Total

530

-

530

330

312

642

 

14. Borrowings

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2017

Year ended

31 March

2018

 

£'000

£'000

£'000

Bank Loan

24,500

32,000

28,000

Arrangement Fee

(102)

(170)

(136)

Finance Leases - Non Current

1,414

3,507

2,807

Total Non-Current

25,812

35,337

30,670

 

 

 

 

Finance Leases - Current

3,091

2,677

3,125

Term Loans

-

2

-

Total Current

3,091

2,679

3,125

 

 

15. Capital and reserves

 

Issued share capital

 

 

Number

£'000

At 30 September 2017

148,859,173

149

Issued during six month period

276,143

-

At 31 March 2018

149,135,316

149

Issued during six the period

-

-

At 30 September 2018

149,135,316

149

 

 

 

16. IFRS15 (Revenue from contracts with customers) restatement

 

There were two main changes to the Company accounts when prepared under IFRS15. The first was in relation to recognition of revenue for Customer Premises Equipment (i.e routers) and the second was in relation to commission payments made to members of the Sales department. The Company has chosen to adopt the retrospective method of transition which allows for the recognition of the cumulative effect of applying the standard through opening retained earnings.

 

Customer Premises Equipment (CPE)

 

Prior to IFRS 15 adoption, CPE set up and activation revenue was recognised up front upon installation. Under IFRS 15 this has now been amended so that all revenue received in relation to CPE set up and activation is now recognised over the life of the relevant customer contract. The impact of this has been a reduction in reported revenue and an equivalent increase in deferred income

 

Sales Commission Payments

 

Prior to IFRS15 adoption, the policy was to recognise the commission expense in the income statement in the period in which it was paid via payroll. Under IFRS15 sales commission costs are now recognised across the life of the contract to which the commission relates. This restatement has had a positive earnings impact alongside an impact on the statement of financial position to reflect a contract asset for commission costs to be recognised over the term of the contract. The Company is also now recognising the liability for future commission payments due as a result of commission already earned (for example through multi-year payments)

 

Income statement for the six months ended 30 September 2018 prepared under IFRS 15 and IAS 18

 

 

Six months to 30 Sept 2018

Six months to 30 Sept 2018

 

IFRS 15

IAS 18

 

£'000

£'000

Revenue

47,452

47,344

Cost of sales

(19,084)

(19,084)

Gross Profit

28,368

28,260

Operating expenditure

(27,918)

(28,071)

Operating Profit

450

189

 

 

 

Analysed as:

 

 

Adjusted EBITDA*

8,115

7,854

Depreciation

(3,493)

(3,493)

Amortisation of intangibles

(3,689)

(3,689)

Non-recurring costs

(243)

(243)

Share-based payments

(204)

(204)

NI on share-based payments

(36)

(36)

Operating Profit

450

189

 

 

 

Net Finance costs

(572)

(572)

Loss on ordinary activities before taxation

(122)

(383)

Tax credit/(charge) on profit on ordinary activities

(449)

(399)

Profit/(Loss) for the year (attributable to owners of the parent)

(571)

(782)

  

 

Statement of financial position at 30 September 2018 prepared under IFRS 15 and IAS 18

 

 

 

30 Sept 2018

30 Sept 2018

 

IFRS 15

IAS 18

 

£'000

£'000

Non-Current Assets

 

 

Property, plant and equipment

19,173

19,173

Intangible assets and goodwill

79,436

79,436

 

98,609

98,609

Current Assets

 

 

Inventories

443

443

Trade and other receivables

22,510

20.983

Cash and short term deposits

6,282

6,282

 

29,235

27,708

 

 

 

Total assets

127,844

126,317

 

 

 

Equity

 

 

Called up share capital

149

149

Share premium account

65,588

65,588

Capital redemption reserve

(9,454)

(9,454)

Retained earnings

21,169

21,032

Total Equity

77,452

77,315

 

 

 

Non-current liabilities

 

 

Loans and borrowings

25,812

25,812

Provisions

530

530

Deferred tax liability

506

506

 

26,848

26,848

Current Liabilities

 

 

Trade and other payables

19,617

18,277

Corporation tax payable

836

786

Loans and borrowings

3,091

3,091

 

23,544

22,154

 

 

 

Total Liabilities

50,392

49,002

 

 

 

Total Equity and Liabilities

127,844

126,317

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BBBBTMBTTTBP
Date   Source Headline
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.